Literature DB >> 12504783

A comparison of the antinociceptive effects of voltage-activated Na+ channel blockers in two rat models of neuropathic pain.

Helle Kirstein Erichsen1, Jing-Xia Hao, Xiao-Jun Xu, Gordon Blackburn-Munro.   

Abstract

The pain-relieving effects of various voltage-activated Na(+) channel blockers have been evaluated in two rat models of neuropathic pain; the photochemically induced nerve injury model (Gazelius) and spared nerve injury model. Lidocaine (up to 40 mg/kg, i.p.) and lamotrigine (up to 60 mg/kg, i.p.) had no effect on mechanical or cold allodynia in either model. However, lamotrigine (10, 30 and 60 mg/kg) significantly attenuated mechanical hyperalgesia in the spared nerve injury model, while mexiletine (25 and 37.5 mg/kg, i.p.) attenuated mechanical allodynia in the Gazelius model. Tocainide (50, 75 and 100 mg/kg, i.p.) significantly reduced all types of pain behaviour measured. The present results show that these voltage-activated Na(+) channel blockers have broadly similar antinociceptive effects in these two models of neuropathic pain. They also show that these drugs can have markedly different effects on distinct neuropathic pain-related behaviours within models.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12504783     DOI: 10.1016/s0014-2999(02)02792-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain.

Authors:  Frederik Rode; Tine Broløs; Gordon Blackburn-Munro; Ole J Bjerrum
Journal:  Psychopharmacology (Berl)       Date:  2006-06-17       Impact factor: 4.530

2.  Ranolazine attenuates behavioral signs of neuropathic pain.

Authors:  Harry J Gould; Colleen Garrett; Renee R Donahue; Dennis Paul; Ivan Diamond; Bradley K Taylor
Journal:  Behav Pharmacol       Date:  2009-12       Impact factor: 2.293

3.  Antinociceptive activities of lidocaine and the nav1.8 blocker a803467 in diabetic rats.

Authors:  Tufan Mert; Yasemin Gunes
Journal:  J Am Assoc Lab Anim Sci       Date:  2012       Impact factor: 1.232

Review 4.  Postherpetic neuralgia: from preclinical models to the clinic.

Authors:  Ada Delaney; Lesley A Colvin; Marie T Fallon; Robert G Dalziel; Rory Mitchell; Susan M Fleetwood-Walker
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 5.  Behavioral models of pain states evoked by physical injury to the peripheral nerve.

Authors:  Linda S Sorkin; Tony L Yaksh
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

6.  Governing role of primary afferent drive in increased excitation of spinal nociceptive neurons in a model of sciatic neuropathy.

Authors:  Graham M Pitcher; James L Henry
Journal:  Exp Neurol       Date:  2008-08-16       Impact factor: 5.330

7.  Neuropathic pain: early spontaneous afferent activity is the trigger.

Authors:  Wenrui Xie; Judith A Strong; Johanna T A Meij; Jun-Ming Zhang; Lei Yu
Journal:  Pain       Date:  2005-08       Impact factor: 7.926

8.  Synthesis and analgesic effects of μ-TRTX-Hhn1b on models of inflammatory and neuropathic pain.

Authors:  Yu Liu; Jianguang Tang; Yunxiao Zhang; Xiaohong Xun; Dongfang Tang; Dezheng Peng; Jianming Yi; Zhonghua Liu; Xiaoliu Shi
Journal:  Toxins (Basel)       Date:  2014-08-13       Impact factor: 4.546

9.  Intrathecal lamotrigine attenuates mechanical allodynia and suppresses microglial and astrocytic activation in a rat model of spinal nerve ligation.

Authors:  Yun-Sik Choi; In-Gu Jun; Sung-Hoon Kim; Jong-Yeon Park
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.